Possibilities of candesartan in the treatment of arterial hypertension

• Pavlova Tatyana V.

Abstract

In the article one of the most important risk factors for cardiovascular system diseases development and progression is considered: arterial hypertension (AH). Its pathogenesis and history of treatment from the perspective of evidence-based medicine (which are represented in form of the most significant clinical trials review) are described in detail. General conclusion is that renin-angiotensin-aldosterone system blockers administration improve prognosis of patients with AH, and improve their survival rates.

Keywords:candesartan, arterial hypertension, treatment, pathogenesis, renin-angiotensin- aldosterone system blockers

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)